CatalystFDA/Bio

REVOLUTION MEDICINES GETS FDA NOD FOR TARGETED PANCREATIC CANCER DRUG - CNBC

FDA approval catalyst for targeted pancreatic cancer drug validates clinical progress.

What changed

FDA approval catalyst for targeted pancreatic cancer drug validates clinical progress.

Why it matters

FDA approval catalyst for targeted pancreatic cancer drug validates clinical progress. — impact context not separately stored; see What changed.

Sources